dc.contributor.author |
Lamba, Chetna Deep |
|
dc.contributor.author |
Oberai, Praveen |
|
dc.contributor.author |
Manchanda, Raj K. |
|
dc.contributor.author |
Rath, Padmalaya |
|
dc.contributor.author |
Bindu, P. Hima |
|
dc.contributor.author |
Padmanabhan, Maya |
|
dc.date.accessioned |
2019-04-11T05:26:41Z |
|
dc.date.available |
2019-04-11T05:26:41Z |
|
dc.date.issued |
2018 |
|
dc.identifier.citation |
Indian Journal of Research In Homoeopathy Vol.12 (1) |
en_US |
dc.identifier.uri |
http://aohindia.in:8080/xmlui/handle/123456789/1837 |
|
dc.description.abstract |
Background and Objectives: This study was conducted with the primary objective of evaluating efficacy of Homoeopathy in establishing the
menstrual regularity with improvement in either ultrasonological findings or hirsutism/acne. The quality of life was also assessed using polycystic
ovary syndrome questionnaire (PCOSQ). Materials and Methods: A single‑blind, randomised, placebo‑controlled pilot study was conducted
from February 2014 to May 2015 at two research centres. The cases fulfilling the eligibility criteria were enrolled (n = 60) and randomised to
either the homoeopathic intervention (HI) (n = 30) or identical placebo (P) (n = 30) with uniform lifestyle modification (LSM) for 6 months.
Results: The menstrual regularity with improvement in other signs/symptoms was observed in 60% of the cases (n = 18) in HI + LSM group
and none (n = 0) in control group (P = 0.001). Statistically significant difference (P = 0.016) was observed in reduction of intermenstrual
duration (from 76.1 ± 37.7 to 46.6 ± 38.7 days) in HI + LSM in comparison to placebo + LSM group (from 93.0 ± 65.2 to 93.9 ± 96.2 days). In
PCOSQ, also, significant improvement was observed in HI group in domains of weight, fertility, emotions and menstrual problems (P < 0.05)
with no difference in body hair (P = 0.708). No change was observed in respect of improvement in the ultrasound findings. Pulsatilla was
the most frequently indicated medicine (n = 12, 40%). Conclusion: HI along with LSM has shown promising outcome; further comparative
study with standard conventional treatment on adequate sample size is desirable. |
en_US |
dc.description.sponsorship |
CCRH |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
Hyperandrogenism |
en_US |
dc.subject |
Lifestyle modification |
en_US |
dc.subject |
Menstrual regularity |
en_US |
dc.subject |
Polycystic ovary syndrome |
en_US |
dc.subject |
Polycystic Ovary Syndrome Questionnaire |
en_US |
dc.title |
Evaluation of homoeopathic treatment in polycystic ovary syndrome: A single‑blind, randomised, placebo‑controlled pilot study |
en_US |
dc.type |
Article |
en_US |